Skip to content
Johann Rupert's Remgro has paid $947 million to take full control of Mediclinic's Southern Africa operations after the Competition Tribunal and all other regulators gave their approval.
South Africa's Competition Tribunal has approved Remgro's $950 million acquisition of Mediclinic Southern Africa, giving Johann Rupert's company full control of 50 private hospitals.
Johann Rupert's Remgro is taking full control of Mediclinic Southern Africa in a $950 million deal as its partnership with MSC splits along home market lines.
Johann Rupert's Remgro lifted its interim dividend by over 80% after headline earnings surged, handing the Rupert family about R80 million in gross payouts.